RecruitingNCT06059053
Outcome of the Semibranch in Pararenal and Thoracoabdominal Aortic Pathologies. A Prospective, Multicentre Registry.
Sponsor
University Hospital Muenster
Enrollment
100 participants
Start Date
Jan 12, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
The goal of this registry is to evaluate the semibranch in branched endovascular aortic repair, which is a new tool in endovascular branched aortic repair.
Eligibility
Min Age: 18 Years
Inclusion Criteria5
- years or older
- Presence of pararenal or thoracoabdominal aortic pathology
- Treatment planned a semibranch device branch from Artivion
- Availability of the patients during the follow up period
- Informing patients about the study and providing written informed consent
Exclusion Criteria2
- Women of childbearing age
- Patients under 18 years
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICESemibranch CMD branched aortic stentgraft
bEVAR with a custom made abdominal aortic multibranch, which incorporates the semibranch design
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06059053
Related Trials
Aortopathy Relationship To Imagery and Kinocardiography Features (ARTIK)
NCT062863581 location
Cardiovascular Health Improvement Project
NCT023062001 location
Safety and Effectiveness of Physician-Modified Fenestrated and Branched Aortic Endografting for the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms
NCT065018721 location
Exoskeleton vs. Standard Lead Apron in EVAR Procedures
NCT075281441 location
AI-CARE: Artificial Intelligence for Cardiovascular Analysis and Risk Evaluation
NCT074383273 locations